Results 161 to 170 of about 62,795 (319)

Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: A nationwide register‐based matched cohort study

British Journal of Haematology, Volume 207, Issue 1, Page 189-200, July 2025.
This study investigates the rate of thrombosis in patients with myeloproliferative neoplasms (MPNs) using population‐based data from Swedish registers. The research focuses on whether attained age or time since diagnosis plays a more significant role in thrombosis risk.
Nurgul Batyrbekova, Malin Hultcrantz, Anna Ravn Landtblom, Robert Szulkin, Paul W. Dickman, Therese M.‐L. Andersson, Elisavet Syriopoulou   +6 more
wiley   +1 more source

On the cellular autoimmune mechanism for eliminating erythrocytes normally and under extreme influences [PDF]

The presence of an autoimmune cellular mechanism for destroying erythrocytes on the basis of results of experiments in vivo is demonstrated in the blood and the organs. This mechanism is made up of a population of immunocompetent killer-lymphocytes which
Anikina, A. Y., Pukhova, Y. I., Shashkin, A. V., Terskov, I. A.   +3 more
core   +1 more source

Clinicopathologic Characteristics and Prognostic Profile of Chronic Myeloid Neoplasms With Somatic NF1 Mutations in Adult Patients

European Journal of Haematology, Volume 115, Issue 1, Page 46-56, July 2025.
ABSTRACT Objectives The clinicopathologic and prognostic features of somatic NF1 mutations have been well studied in pediatric myeloid neoplasms and adult acute myeloid leukemia (AML) but not in adult chronic myeloid neoplasms (CMNs), including myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPNs), and myelodysplastic/myeloproliferative ...
Hamza Tariq, Margarita Loxas, Mir B. Alikhan, Juehua Gao, Xinyan Lu, Qing Ching Chen, Yi‐Hua Chen, Jessica K. Altman, Lawrence J. Jennings, Madina Sukhanova   +9 more
wiley   +1 more source

Polycythemia in Nephrotic Syndrome

Indian Journal of Kidney Diseases
The association of polycythemia with kidney diseases such as adult polycystic kidney disease, kidney tumors, and renal artery stenosis is well known. However, polycythemia associated with nephrotic syndrome (NS) is rarely seen and documented.
Anagha Auradkar, Sandhya Suresh, Ramprasad Elumalai   +2 more
doaj   +1 more source

Molecular mechanisms in haematological malignancies [PDF]

, 2009
Haematopoiesis requires the constant production of large numbers of peripheral blood cells. This process is under tight control of transcription factor networks as well as cytokines, growth factors and hormones.
Avellino, Roberto, Grech, Godfrey, Schembri-Wismayer, Pierre   +2 more
core  

THE SERUM CALCIUM IN POLYCYTHEMIA VERA [PDF]

, 1930
Ethel M. Benedict, Kenneth B. Turner
openalex   +1 more source

Advances in Understanding Adaptive Hemoglobin Concentration at High Altitude

American Journal of Human Biology, Volume 37, Issue 7, July 2025.
Ainash Childebayeva, Kimberly Zhu, Abigail W. Bigham   +2 more
wiley   +1 more source

Unmasking Anti‐CASPR2 Syndrome in a Patient Treated for Myasthenia Gravis in the Era of New Treatments

European Journal of Neurology, Volume 32, Issue 7, July 2025.
ABSTRACT Introduction Myasthenia gravis (MG) is an autoimmune disorder characterised by autoantibodies against the acetylcholine receptor (AChR‐Ab). Morvan syndrome (MoS) is a rarer autoimmune disease with neuromyotonia, dysautonomia and encephalopathy, associated with antibodies targeting contactin‐associated protein‐like 2 (CASPR2) and may coexist ...
Vincent Fabry, Celso Rual, Chloé Bost, Blandine Acket, Julien Maquet, Pascal Cintas   +5 more
wiley   +1 more source

Nine treatments of 1000 mL therapeutic phlebotomy in a subject with polycythemia: A case report

Physiological Reports
Large‐volume therapeutic phlebotomy is the mainstay of hemochromatosis treatment and offers an opportunity to investigate the hemodynamic changes during acute hypovolemia. An otherwise healthy 64‐year‐old male with hemochromatosis participated.
William J. Morton, Anton Hauge, Helge Opdahl, Erling Bekkestad Rein, Signe Søvik, Jonny Hisdal   +5 more
doaj   +1 more source

Redefining chronic mountain sickness: insights from high-altitude research and clinical experience

Medical Review
Chronic Mountain Sickness (CMS), characterized by increased red blood cells above average values traditionally attributed to chronic hypobaric hypoxia exposure, is being redefined in light of recent research and clinical experience. We propose a shift in
Zubieta-Calleja Gustavo
doaj   +1 more source